Global Natural Killer (NK) Cell Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 111236
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Natural Killer (NK) Cell Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Natural Killer (NK) Cell Therapeutics market size is estimated to be worth US$ 263.2 million in 2021 and is forecast to a readjusted size of USD 1102.1 million by 2028 with a CAGR of 22.7% during review period. Cancer accounting for % of the Natural Killer (NK) Cell Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Mogamulizumab segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Natural Killer (NK) Cell Therapeutics include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, and Takeda, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Natural Killer (NK) Cell Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Mogamulizumab

Lorvotuzumab Mertansine

Others

Market segment by Application, can be divided into

Cancer

Cardiovascular Diseases

Others

Market segment by players, this report covers

Chipscreen Biosciences

Affimed NV

Altor BioScience

Innate Pharma

Takeda

Sorrento Therapeutics

NantKwest

Bristol-Myers Squibb

NKT

Henry Ford Health Services

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Natural Killer (NK) Cell Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Natural Killer (NK) Cell Therapeutics, with revenue, gross margin and global market share of Natural Killer (NK) Cell Therapeutics from 2019 to 2022.

Chapter 3, the Natural Killer (NK) Cell Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Natural Killer (NK) Cell Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Natural Killer (NK) Cell Therapeutics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Natural Killer (NK) Cell Therapeutics

1.2 Classification of Natural Killer (NK) Cell Therapeutics by Type

1.2.1 Overview: Global Natural Killer (NK) Cell Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type in 2021

1.2.3 Mogamulizumab

1.2.4 Lorvotuzumab Mertansine

1.2.5 Others

1.3 Global Natural Killer (NK) Cell Therapeutics Market by Application

1.3.1 Overview: Global Natural Killer (NK) Cell Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Cancer

1.3.3 Cardiovascular Diseases

1.3.4 Others

1.4 Global Natural Killer (NK) Cell Therapeutics Market Size & Forecast

1.5 Global Natural Killer (NK) Cell Therapeutics Market Size and Forecast by Region

1.5.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Natural Killer (NK) Cell Therapeutics Market Size by Region, (2017-2022)

1.5.3 North America Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2017-2028)

1.5.4 Europe Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2017-2028)

1.5.6 South America Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Natural Killer (NK) Cell Therapeutics Market Drivers

1.6.2 Natural Killer (NK) Cell Therapeutics Market Restraints

1.6.3 Natural Killer (NK) Cell Therapeutics Trends Analysis

2 Company Profiles

2.1 Chipscreen Biosciences

2.1.1 Chipscreen Biosciences Details

2.1.2 Chipscreen Biosciences Major Business

2.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product and Solutions

2.1.4 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Chipscreen Biosciences Recent Developments and Future Plans

2.2 Affimed NV

2.2.1 Affimed NV Details

2.2.2 Affimed NV Major Business

2.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Product and Solutions

2.2.4 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Affimed NV Recent Developments and Future Plans

2.3 Altor BioScience

2.3.1 Altor BioScience Details

2.3.2 Altor BioScience Major Business

2.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Product and Solutions

2.3.4 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Altor BioScience Recent Developments and Future Plans

2.4 Innate Pharma

2.4.1 Innate Pharma Details

2.4.2 Innate Pharma Major Business

2.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Product and Solutions

2.4.4 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Innate Pharma Recent Developments and Future Plans

2.5 Takeda

2.5.1 Takeda Details

2.5.2 Takeda Major Business

2.5.3 Takeda Natural Killer (NK) Cell Therapeutics Product and Solutions

2.5.4 Takeda Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Takeda Recent Developments and Future Plans

2.6 Sorrento Therapeutics

2.6.1 Sorrento Therapeutics Details

2.6.2 Sorrento Therapeutics Major Business

2.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product and Solutions

2.6.4 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Sorrento Therapeutics Recent Developments and Future Plans

2.7 NantKwest

2.7.1 NantKwest Details

2.7.2 NantKwest Major Business

2.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Product and Solutions

2.7.4 NantKwest Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 NantKwest Recent Developments and Future Plans

2.8 Bristol-Myers Squibb

2.8.1 Bristol-Myers Squibb Details

2.8.2 Bristol-Myers Squibb Major Business

2.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product and Solutions

2.8.4 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.9 NKT

2.9.1 NKT Details

2.9.2 NKT Major Business

2.9.3 NKT Natural Killer (NK) Cell Therapeutics Product and Solutions

2.9.4 NKT Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 NKT Recent Developments and Future Plans

2.10 Henry Ford Health Services

2.10.1 Henry Ford Health Services Details

2.10.2 Henry Ford Health Services Major Business

2.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product and Solutions

2.10.4 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Henry Ford Health Services Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Natural Killer (NK) Cell Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Natural Killer (NK) Cell Therapeutics Players Market Share in 2021

3.2.2 Top 10 Natural Killer (NK) Cell Therapeutics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Natural Killer (NK) Cell Therapeutics Players Head Office, Products and Services Provided

3.4 Natural Killer (NK) Cell Therapeutics Mergers & Acquisitions

3.5 Natural Killer (NK) Cell Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Natural Killer (NK) Cell Therapeutics Revenue and Market Share by Type (2017-2022)

4.2 Global Natural Killer (NK) Cell Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2017-2022)

5.2 Global Natural Killer (NK) Cell Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2017-2028)

6.2 North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2017-2028)

6.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Country

6.3.1 North America Natural Killer (NK) Cell Therapeutics Revenue by Country (2017-2028)

6.3.2 United States Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

6.3.3 Canada Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

6.3.4 Mexico Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2017-2028)

7.2 Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2017-2028)

7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country

7.3.1 Europe Natural Killer (NK) Cell Therapeutics Revenue by Country (2017-2028)

7.3.2 Germany Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

7.3.3 France Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

7.3.5 Russia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

7.3.6 Italy Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2017-2028)

8.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2017-2028)

8.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region

8.3.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Region (2017-2028)

8.3.2 China Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

8.3.3 Japan Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

8.3.4 South Korea Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

8.3.5 India Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

8.3.7 Australia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Natural Killer (NK) Cell Therapeutics Revenue by Type (2017-2028)

9.2 South America Natural Killer (NK) Cell Therapeutics Revenue by Application (2017-2028)

9.3 South America Natural Killer (NK) Cell Therapeutics Market Size by Country

9.3.1 South America Natural Killer (NK) Cell Therapeutics Revenue by Country (2017-2028)

9.3.2 Brazil Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

9.3.3 Argentina Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2017-2028)

10.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2017-2028)

10.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country

10.3.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Country (2017-2028)

10.3.2 Turkey Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

10.3.4 UAE Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Natural Killer (NK) Cell Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Natural Killer (NK) Cell Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Natural Killer (NK) Cell Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region (2023-2028)

Table 6. Chipscreen Biosciences Corporate Information, Head Office, and Major Competitors

Table 7. Chipscreen Biosciences Major Business

Table 8. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product and Solutions

Table 9. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Affimed NV Corporate Information, Head Office, and Major Competitors

Table 11. Affimed NV Major Business

Table 12. Affimed NV Natural Killer (NK) Cell Therapeutics Product and Solutions

Table 13. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Altor BioScience Corporate Information, Head Office, and Major Competitors

Table 15. Altor BioScience Major Business

Table 16. Altor BioScience Natural Killer (NK) Cell Therapeutics Product and Solutions

Table 17. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Innate Pharma Corporate Information, Head Office, and Major Competitors

Table 19. Innate Pharma Major Business

Table 20. Innate Pharma Natural Killer (NK) Cell Therapeutics Product and Solutions

Table 21. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Takeda Corporate Information, Head Office, and Major Competitors

Table 23. Takeda Major Business

Table 24. Takeda Natural Killer (NK) Cell Therapeutics Product and Solutions

Table 25. Takeda Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors

Table 27. Sorrento Therapeutics Major Business

Table 28. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product and Solutions

Table 29. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. NantKwest Corporate Information, Head Office, and Major Competitors

Table 31. NantKwest Major Business

Table 32. NantKwest Natural Killer (NK) Cell Therapeutics Product and Solutions

Table 33. NantKwest Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 35. Bristol-Myers Squibb Major Business

Table 36. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product and Solutions

Table 37. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. NKT Corporate Information, Head Office, and Major Competitors

Table 39. NKT Major Business

Table 40. NKT Natural Killer (NK) Cell Therapeutics Product and Solutions

Table 41. NKT Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Henry Ford Health Services Corporate Information, Head Office, and Major Competitors

Table 43. Henry Ford Health Services Major Business

Table 44. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product and Solutions

Table 45. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Natural Killer (NK) Cell Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Natural Killer (NK) Cell Therapeutics Players Head Office, Products and Services Provided

Table 50. Natural Killer (NK) Cell Therapeutics Mergers & Acquisitions in the Past Five Years

Table 51. Natural Killer (NK) Cell Therapeutics New Entrants and Expansion Plans

Table 52. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) by Type (2017-2022)

Table 53. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Type (2017-2022)

Table 54. Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Type (2023-2028)

Table 55. Global Natural Killer (NK) Cell Therapeutics Revenue by Application (2017-2022)

Table 56. Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Application (2023-2028)

Table 57. North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Natural Killer (NK) Cell Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Natural Killer (NK) Cell Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Natural Killer (NK) Cell Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Natural Killer (NK) Cell Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Natural Killer (NK) Cell Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Natural Killer (NK) Cell Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Natural Killer (NK) Cell Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Natural Killer (NK) Cell Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Natural Killer (NK) Cell Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Natural Killer (NK) Cell Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Natural Killer (NK) Cell Therapeutics Picture

Figure 2. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type in 2021

Figure 3. Mogamulizumab

Figure 4. Lorvotuzumab Mertansine

Figure 5. Others

Figure 6. Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application in 2021

Figure 7. Cancer Picture

Figure 8. Cardiovascular Diseases Picture

Figure 9. Others Picture

Figure 10. Global Natural Killer (NK) Cell Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Natural Killer (NK) Cell Therapeutics Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region (2017-2028)

Figure 13. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region in 2021

Figure 14. North America Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Natural Killer (NK) Cell Therapeutics Market Drivers

Figure 20. Natural Killer (NK) Cell Therapeutics Market Restraints

Figure 21. Natural Killer (NK) Cell Therapeutics Market Trends

Figure 22. Chipscreen Biosciences Recent Developments and Future Plans

Figure 23. Affimed NV Recent Developments and Future Plans

Figure 24. Altor BioScience Recent Developments and Future Plans

Figure 25. Innate Pharma Recent Developments and Future Plans

Figure 26. Takeda Recent Developments and Future Plans

Figure 27. Sorrento Therapeutics Recent Developments and Future Plans

Figure 28. NantKwest Recent Developments and Future Plans

Figure 29. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 30. NKT Recent Developments and Future Plans

Figure 31. Henry Ford Health Services Recent Developments and Future Plans

Figure 32. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Players in 2021

Figure 33. Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 34. Global Top 3 Players Natural Killer (NK) Cell Therapeutics Revenue Market Share in 2021

Figure 35. Global Top 10 Players Natural Killer (NK) Cell Therapeutics Revenue Market Share in 2021

Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 37. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Type in 2021

Figure 38. Global Natural Killer (NK) Cell Therapeutics Market Share Forecast by Type (2023-2028)

Figure 39. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Application in 2021

Figure 40. Global Natural Killer (NK) Cell Therapeutics Market Share Forecast by Application (2023-2028)

Figure 41. North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2017-2028)

Figure 42. North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2017-2028)

Figure 43. North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2017-2028)

Figure 44. United States Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Canada Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Mexico Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2017-2028)

Figure 48. Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2017-2028)

Figure 49. Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2017-2028)

Figure 50. Germany Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. France Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. United Kingdom Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Russia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Italy Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Asia-Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2017-2028)

Figure 56. Asia-Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2017-2028)

Figure 57. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region (2017-2028)

Figure 58. China Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Japan Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. South Korea Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. India Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Southeast Asia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Australia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2017-2028)

Figure 65. South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2017-2028)

Figure 66. South America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2017-2028)

Figure 67. Brazil Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Argentina Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2017-2028)

Figure 70. Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2017-2028)

Figure 71. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2017-2028)

Figure 72. Turkey Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Saudi Arabia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. UAE Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Methodology

Figure 76. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz